The Recall Desk
Agency classClass IIOur severity:HighFDA (Drugs)·D-0968-2022·Announced 2022-06-08

Rocuronium Bromide Injection Recalled Due to Lack of Sterility Assurance

Nephron Sterile Compounding Center is recalling Rocuronium Bromide Injection pre-filled syringes nationwide due to lack of sterility assurance. Approximately 604,080 syringes are affected.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 3/5 (High).

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: This is a Class II FDA recall of an injectable medication with no reported illnesses or injuries. Lack of sterility assurance represents a significant theoretical risk to injectable drug users, consistent with the rubric criterion for risk-of-harm products where injury has not yet been reported.

Plain-English summary

Nephron Sterile Compounding Center LLC is recalling Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL), Preservative Free, 5 mL pre-filled syringes due to lack of assurance of sterility. The recall affects approximately 604,080 syringes distributed nationwide.

The affected product is supplied in 5 x 5 mL pre-filled syringe packs and 6 x 5 syringe cartons. Specific lot codes affected are: RC1050A (Exp. 5/30/2022), RC1051B (Exp. 6/6/2022), RC1053A (Exp. 6/27/2022), RC2001A (Exp. 7/19/2022), RC2002A (Exp. 8/13/2022), RC2003A (Exp. 8/28/2022), and RC2004A (Exp. 9/8/2022). The product was manufactured by Nephron Sterile Compounding Center LLC at 4500 12th Street Extension, West Columbia, SC 29172.

Healthcare providers and hospitals should immediately discontinue use of the affected lot codes and quarantine any remaining product. Patients who have received this medication should contact their healthcare provider for guidance. No illnesses or adverse events related to this recall have been reported.

The recalled product

Product
Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL), Preservative Free, 5 mL Pre-Filled Syringe, 5 x 5 mL Pre-Filled Syringes, 6 x 5 Syringe Carton, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-924-05
Manufacturer
Nephron Sterile Compounding Center LLC
Category
Drug — Injectable / Parenteral
Hazard
Affected units
604,080

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (14)

  • Lots: RC1050A
  • Exp. 5/30/2022
  • RC1051B
  • Exp. 6/6/2022
  • RC1053A
  • Exp. 6/27/2022
  • RC2001A
  • Exp. 7/19/2022
  • RC2002A
  • Exp. 8/13/2022
  • RC2003A
  • Exp. 8/28/2022
  • RC2004A
  • Exp. 9/8/2022

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 20 recalled by Nephron Sterile Compounding Center LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 20 products in this recall →

Related recalls

Same manufacturer · Nephron Sterile Compounding Center LLC

See all →

Same hazard · lack of sterility

See all →

Similar recalls